Glycemic Control Rate in Patients With Type 1 Diabetes Treated at a Public Tertiary Referral Hospital in Rio de Janeiro, Brazil

Raissa Barros Mota, Elisa Baranski Lamback, Natasha Reis Lozovey, Michelle Botelho Caarls, Mariana Arruda, Leonardo Vieira Neto

Abstract


Background: The incidence of type 1 diabetes (T1D) has been increasing worldwide, leading to a serious public health problem resulting in reduced life expectancy and increased morbidity. The aim of this study was to determine the glycemic control rate and its demographic and clinical factors, in T1D followed up at a tertiary referral hospital in Brazil.

Methods: An observational and retrospective study was conducted between October 2014 and October 2015. Data were obtained from 140 medical records.

Results: Satisfactory glycemic control rate was found in 22.14% of patients. There was no difference between the pediatric group and adult group regarding control rate. However, a worse HbA1C level was found in the pediatric group (P = 0.001). The use of long-acting insulin analogue (P = 0.03) was associated with satisfactory glycemic control, and a tendency was observed for both the combination of long-acting and ultra-rapid acting analogues (P = 0.08), and the absence of ketoacidosis during the course of diabetes (P = 0.08). In the group with satisfactory glycemic control, the median number of consultations (1 (1 - 4)) was significantly lower than in the uncontrolled group (2 (1 - 4)) (P = 0.003). Regarding the two major microvascular complications, 23.53% had retinopathy and 12.09% had nephropathy.

Conclusions: The majority of patients did not obtain a satisfactory HbA1C level. Good glycemic control factors were directly associated with the use of long-acting insulin analogues, and the combination of long-acting and ultra-rapid analogues as well as the absence of ketoacidosis during T1D’s evolution tended also to be associated with better metabolic control.




J Endocrinol Metab. 2016;6(5):135-142
doi: http://dx.doi.org/10.14740/jem369w

 


Keywords


Type 1 diabetes mellitus; Glycosylated hemoglobin A; Brazil

Full Text: HTML PDF
 

Browse  Journals  

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.